Infectious virus outbreaks pose a significant challenge to public healthcare systems. Early
and accurate virus diagnosis is critical to prevent the spread of the virus, especially when no …

Traditional diagnostic strategies for infectious disease detection require benchtop
instruments that are inappropriate for point-of-care testing (POCT). Emerging microfluidics, a …

Fast, inexpensive, and multiplexed detection of multiple nucleic acids is of great importance
to human health, yet it still represents a significant challenge. Herein, we propose a nucleic …

Human-infecting pathogens that transmit through the air pose a significant threat to public
health. As a prominent instance, the severe acute respiratory syndrome coronavirus 2 …

Microfluidic biosensors integrating fluid control, target recognition, as well as signal
transduction and output, have been widely used in the field of disease diagnosis, drug …

Abstract The Coronavirus disease 2019 (COVID-19) outbreak has urged the establishment
of a global-wide rapid diagnostic system. Current widely-used tests for COVID-19 include …

In recent years, there has been a notable increase in interest surrounding nanozymes due to
their ability to imitate the functions and address the limitations of natural enzymes. The …

The global outbreaks of infectious diseases have significantly driven an imperative demand
for rapid and accurate molecular diagnostics. Nucleic acid amplification tests (NAATs) …

There remains an unmet need for a fully integrated microfluidic platform that can
automatically perform multistep and multireagent immunoassays. Here, we proposed a …

Given the continuous and growing demand for point of care (POC) diagnostic tests, attention
has been shifted toward integration and miniaturization of laboratory protocols into “sample …